Literature DB >> 24420723

Clinical parameter and Th17 related to lymphocytes infiltrating degree of labial salivary gland in primary Sjögren's syndrome.

Yunyun Fei1, Wen Zhang, Dongfang Lin, Chen Wu, Mengtao Li, Yan Zhao, Xiaofeng Zeng, Fengchun Zhang.   

Abstract

The aim of this study is to investigate the correlation between clinical parameter, Th17, and degree of lymphocytes infiltrating in labial salivary gland in primary Sjögren's syndrome (pSS). Minor labial gland biopsies from a cohort of 103 patients fulfilling the American-European consensus classification criteria for pSS were examined and grouped into G1 to G3 according to infiltration degree of lymphocytes in labial salivary glands and formation of germinal center. IL-17 level and Th17 proportion of peripheral blood samples in 54 patients with pSS were analyzed simultaneously. Among the 103 labial salivary glands samples, there were 10.5 % of G1, 68.4 % of G2, and 21.1 % of G3, respectively. Some clinical parameters were markedly associated with the degree of inflammatory cells infiltration in labial glands, including white blood cell counts, lymphocytes, liver enzymes, and pulmonary function diffusion rates. The average optical density of IL-17 correlated with the severity of lymphocytic infiltration in the labial glands, while the proportion of Th17 cells in the peripheral blood mononuclear cells showed no significant relationship to the degree of lymphocytic infiltration in the labial glands from the SS patients. IL-17A mRNA levels in peripheral blood mononuclear cells from pSS patients before immunosuppressant treatment were significantly higher than that in patients after immunosuppressant treatment. The degree of inflammatory cells infiltration in labial glands was related to some clinical manifestations in pSS. IL-17 may play a role in the pathogenesis of lymphocytic infiltration in the labial glands. Immunosuppressive treatment might affect Th17 cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24420723     DOI: 10.1007/s10067-013-2476-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

Review 1.  T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology.

Authors:  Gikas E Katsifis; Niki M Moutsopoulos; Sharon M Wahl
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 2.  The role of ectopic germinal centers in the immunopathology of primary Sjögren's syndrome: a systematic review.

Authors:  Anna P Risselada; Marjolein F Looije; Aike A Kruize; Johannes W J Bijlsma; Joel A G van Roon
Journal:  Semin Arthritis Rheum       Date:  2012-09-18       Impact factor: 5.532

Review 3.  Germinal centers.

Authors:  I C MacLennan
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

4.  Reevaluation of laboratory parameters in relation to histological findings in primary and secondary Sjögren's syndrome.

Authors:  T Ohara; Y Itoh; K Itoh
Journal:  Intern Med       Date:  2000-06       Impact factor: 1.271

Review 5.  The etiopathogenesis of Sjögren's syndrome.

Authors:  E J Price; P J Venables
Journal:  Semin Arthritis Rheum       Date:  1995-10       Impact factor: 5.532

6.  Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.

Authors:  Chun Kwok Wong; Lydia Choi Wan Lit; Lai Shan Tam; Edmund Kwok Ming Li; Purple Tsz Yan Wong; Christopher Wai Kei Lam
Journal:  Clin Immunol       Date:  2008-03-25       Impact factor: 3.969

7.  Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice.

Authors:  Cuong Q Nguyen; Min H Hu; Yi Li; Carol Stewart; Ammon B Peck
Journal:  Arthritis Rheum       Date:  2008-03

8.  Selective localization of T helper subsets in labial salivary glands from primary Sjögren's syndrome patients.

Authors:  T Maehara; M Moriyama; J-N Hayashida; A Tanaka; S Shinozaki; Y Kubo; K Matsumura; S Nakamura
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

9.  Cytokine/chemokine profiles contribute to understanding the pathogenesis and diagnosis of primary Sjögren's syndrome.

Authors:  M Moriyama; J-N Hayashida; T Toyoshima; Y Ohyama; S Shinozaki; A Tanaka; T Maehara; S Nakamura
Journal:  Clin Exp Immunol       Date:  2012-07       Impact factor: 4.330

10.  Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis.

Authors:  Jimyung Kim; Seongwook Kang; Jinhyun Kim; Gyechul Kwon; Sunhoe Koo
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

View more
  16 in total

Review 1.  Th17 cells in autoimmune diseases.

Authors:  Lei Han; Jing Yang; Xiuwen Wang; Dan Li; Ling Lv; Bin Li
Journal:  Front Med       Date:  2015-02-04       Impact factor: 4.592

2.  IL-17, a potential therapeutic target for Sjögren's syndrome?

Authors:  Shan-Shan Liu; Ye Ding; Ji-Quan Lou
Journal:  Clin Rheumatol       Date:  2014-04-22       Impact factor: 2.980

3.  A pathogenetic role for IL-21 in primary Sjögren syndrome.

Authors:  Seung-Ki Kwok; Jennifer Lee; Di Yu; Kwi Young Kang; Mi-La Cho; Hae-Rim Kim; Ji Hyeon Ju; Sang-Heon Lee; Sung-Hwan Park; Ho-Youn Kim
Journal:  Nat Rev Rheumatol       Date:  2015-01-13       Impact factor: 20.543

4.  Focal lymphocytic sialadenitis and ectopic germinal centers in oral reactive lesions and primary Sjögren's syndrome: a comparative study.

Authors:  Evânio Vilela Silva; Luciana Yamamoto Almeida; Karen Cristine Bortoletto; Isabela Barbosa Quero; Fernanda Carolina Jacomini; Bruno Augusto Benevenuto de Andrade; Heitor Albergoni Silveira; Andressa Duarte; Flávio Calil Petean; Eduardo Melani Rocha; Alfredo Ribeiro-Silva; Román Carlos; Jorge Esquiche León
Journal:  Rheumatol Int       Date:  2021-07-20       Impact factor: 3.580

5.  The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sjögren's Syndrome.

Authors:  Linbo Li; Jing He; Lei Zhu; Yuqin Yang; Yuebo Jin; Rulin Jia; Xu Liu; Yanying Liu; Xiaolin Sun; Zhanguo Li
Journal:  J Immunol Res       Date:  2015-09-08       Impact factor: 4.818

Review 6.  T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives.

Authors:  Alessia Alunno; Francesco Carubbi; Onelia Bistoni; Sara Caterbi; Elena Bartoloni; Giulia Mirabelli; Francesca Cannarile; Paola Cipriani; Roberto Giacomelli; Roberto Gerli
Journal:  Mediators Inflamm       Date:  2015-04-28       Impact factor: 4.711

7.  Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.

Authors:  Yuzhou Gan; Xiaozhen Zhao; Jing He; Xu Liu; Yun Li; Xiaolin Sun; Zhanguo Li
Journal:  J Immunol Res       Date:  2017-01-22       Impact factor: 4.818

8.  Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.

Authors:  Eunhye Park; Donghee Kim; Song Mi Lee; Hee-Sook Jun
Journal:  Oncotarget       Date:  2017-04-18

9.  Ectopic germinal center and megalin defect in primary Sjogren syndrome with renal Fanconi syndrome.

Authors:  Jing Wang; Yubing Wen; Mengyu Zhou; Xiaoxiao Shi; Lanping Jiang; Mingxi Li; Yang Yu; Xuemei Li; Xuewang Li; Wen Zhang; Andrew L Lundquist; Limeng Chen
Journal:  Arthritis Res Ther       Date:  2017-06-02       Impact factor: 5.156

Review 10.  T Helper 17 Cells in Primary Sjögren's Syndrome.

Authors:  Kiyoshi Matsui; Hajime Sano
Journal:  J Clin Med       Date:  2017-07-05       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.